Osagie has over 30 years of experience in the fields of law, finance and business management, healthcare and the pharmaceutical industry. Prior to co-founding PIPV Capital, Osagie conceptualized and established GSK Ventures and was its founding Vice President. Osagie led GSK Ventures in concluding over thirty (30) worldwide transactions within a three-year period, in which he invested various GSK R&D non-progressed assets into various companies and/or as the basis of starting new companies.
Prior to this role within GSK, Osagie was a Vice President for Product Development Strategy at SmithKline Beecham. Prior to this role at SmithKline, Osagie was the Founding Senior Vice President for Business Development and General Counsel at Endo Pharmaceuticals Inc. Osagie previously served as a DuPont Merck Vice President for International Sales and Marketing and General Counsel to DuPont Merck’s International, Manufacturing and Generic Drug Divisions. Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a practicing attorney with a leading U.S. Law Firm, Schnader, Harrison, Segal & Lewis, in the fields of corporate, corporate finance, taxation and intellectual property law.
Osagie was a co-Founder and former President, CEO and Chairman of Ception Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of novel products to address unmet medical needs. Osagie was also the Founder of Trigenesis Therapeutics Inc., a biopharmaceutical company focused on developing pharmaceutical products for the dermatological market which he sold to Dr. Reddy’s Pharmaceuticals. Osagie is Chairman of the Board of Directors of Ilera Healthcare. In addition, he serves on the Board of StoneRidge Investment Partners, a Money Management Firm with over $2 billion under management and of the Haverford Trust Company with over $6 billion under management and of FS-KKR with over $17 billion under management/advice.
In addition, Osagie is a member of the Board of Trustees of the University of Pennsylvania and the Board of Overseers of the University of Pennsylvania Law School. Osagie is also the 2008 recipient of the Penn Law School Alumni Award of Merit. Osagie serves on the Board of a number of non-for-profit organizations and institutions such as the Philadelphia Orchestra and the Philadelphia Museum of Art. Osagie also served as a Senior Consultant to the President’s Emergency Plan for AIDS Relief (“PEPFAR”), a unique initiative by the United States Government to have a direct, positive impact in the fight against the global AIDS epidemic by committing, currently, over USD 48 billion and a multifaceted approach to combating HIV/AIDS on a worldwide basis.
Osagie holds post-graduate degrees from the London School of Economics and the University of Pennsylvania Law School, and is a member of the New York State Bar. In addition, Osagie has served as the I Grant Irey Adjunct Professor at the University of Pennsylvania Law School where he teaches a seminar on “Intellectual Property and National Economic Value Creation.”